Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
J Biomol Struct Dyn ; 39(16): 5940-5952, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-32715978

RESUMO

Chagasin, an endogenous cysteine protease inhibitor from Trypanosoma cruzi, can control the activity of the parasitic cruzain and its homologous human cathepsin L. While chagasin inhibits both enzymes with similar potency, mutations have different effects on binding to these enzymes. Mutants T31A and T31A/T32A bind well to cathepsin L, but their affinity for cruzain drops ∼40 to 140-fold. On the other hand, the mutant W93A binds well to cruzain, but it loses potency against cathepsin L. Here, we employed molecular dynamics simulations to understand the selectivity in inhibition of cruzain or cathepsin L by chagasin mutants W93A, T31A, and T31A/T32A. Our results allowed profiling the nonbonded interactions in the interfaces of each mutant with these cysteine proteases. Additionally, we observed differences in the binding conformation of the chagasin loops L2 and L6 of the W93A mutant, favoring interactions with cruzain and reducing interactions with cathepsin L. These differences are associated with a partial dissociation of the W93A-cathepsin L complex, providing a likely cause for the selectivity of the mutant W93A towards cruzain.Communicated by Ramaswamy H. Sarma.


Assuntos
Cisteína Proteases , Trypanosoma cruzi , Catepsina L/genética , Cisteína Endopeptidases , Cisteína Proteases/genética , Inibidores de Cisteína Proteinase/farmacologia , Humanos , Simulação de Dinâmica Molecular , Proteínas de Protozoários/genética , Trypanosoma cruzi/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...